FDA Approves NSCLC Treatment Acquired by GSK in Nuvalent Deal
FDA Approves NSCLC Treatment Acquired by GSK in Nuvalent Deal Contract Pharma
Regulatory Approvals
FDA clears Momentis Surgical’s multiport surgical robot
FDA clears Momentis Surgical’s multiport surgical robot MassDevice
FDA Approves Zidesamtinib for Pretreated ROS1-Positive NSCLC
FDA Approves Zidesamtinib for Pretreated ROS1-Positive NSCLC Oncology Nursing News
FDA Approval of Perioperative EV/Pembrolizumab Reshapes MIBC Treatment Paradigm
FDA Approval of Perioperative EV/Pembrolizumab Reshapes MIBC Treatment Paradigm OncLive
GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug
GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug BioSpace